Douglas A. Melton

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Script error: No such module "Template wrapper".Script error: No such module "Check for clobbered parameters".

Douglas A. Melton is an American medical researcher who is the Xander University Professor at Harvard University, and was an investigator at the Howard Hughes Medical Institute until 2022.[1] Melton is a co-director of the Harvard Stem Cell Institute and was an original co-chairman (with David Scadden) of the Harvard University Department of Stem Cell and Regenerative Biology. Melton founded of several biotech companies including Gilead Sciences, Ontogeny (now Curis), iPierian (now True North Therapeutics Template:Webarchive), and Semma Therapeutics. Melton is a member of the National Academy of the Sciences,[2] the American Academy of Arts and Sciences, and is a founding member of the International Society for Stem Cell Research.[3]

Early life and education

Melton grew up in Blue Island, Illinois[4] and completed a Bachelor of Science degree in biology at the University of Illinois at Urbana–Champaign in 1975.[5] He was awarded a Marshall Scholarship for study at the University of Cambridge where he received a Bachelor of Arts degree in the history and philosophy of science in 1977 and a PhD under the supervision of John Gurdon.[6][7]

Career and research

Melton's early work was in general developmental biology, identifying genes important for cell fate determination and body pattern. This led to the finding that the nervous system in vertebrates is formed as a default when early embryonic cells do not receive inductive signals to become mesoderm or endoderm.[8] He also pioneered the technique of in vitro transcription with bacterial SP6 RNA polymerase.[9] This RNA transcription system is now widely used to make large amounts of messenger RNAs in vitro and is, for example, the basis for production of the COVID mRNA vaccines.Script error: No such module "Unsubst".

In the mid-1990s, work in his lab became centered on the development of the pancreas aiming to find new treatments for diabetes.

In 2001 when President George W. Bush cut federal funding of embryonic stem cell research, Melton used private donations to create 17 published[10][11] human stem cell lines and distributed them without charge to researchers around the world.

In August 2008, Melton's lab published successful in vivo reprogramming of adult mice exocrine pancreatic cells into insulin secreting cells which closely resembled endogenous islet beta cells of the pancreas in terms of their size, shape, ultrastructure, and essential marker genes.[12] Unlike producing beta cells from conventional embryonic stem cells or the more recently developed induced pluripotent stem cell (iPSC) technique, Melton's method involved direct cell reprogramming of an adult cell type (exocrine cell) into other adult cell type (beta cell) without reversion to a pluripotent stem cell state.

His current research interests include pancreatic developmental biology and the directed differentiation of human embryonic stem cells, particularly in pertinence to type 1 diabetes. In 2014, he reported a method using human pluripotent stem cells to generate virtually unlimited quantities of functional insulin-producing beta cells that respond appropriately to a glucose challenge.[13]

In 2022, Melton left Harvard University and joined Vertex Pharmaceuticals full-time to create diabetes treatments.[14]

Awards and honors

Melton was elected a member of the National Academy of Sciences and the American Academy of Arts and Sciences in 1995. In 2007 and again in 2009, Melton was listed among the Time 100 Most Influential People in the World.[15] In 2016, Melton was awarded the Ogawa-Yamanaka Prize in Stem Cell Biology.[16] In 2023 he received the Abarca Prize for his advances towards a cure for diabetes.[17]

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ Script error: No such module "citation/CS1".
  2. ↑ Douglas A. Melton, Harvard University
  3. ↑ Fox, Michael J. (May 3, 2007). "The 2007 Time 100: Douglas Melton". Time.
  4. ↑ Script error: No such module "Citation/CS1".
  5. ↑ Doug Melton's Curriculum Vitae
  6. ↑ Cite error: Script error: No such module "Namespace detect".Script error: No such module "Namespace detect".
  7. ↑ Template:Cite thesis
  8. ↑ Template:Cite Q
  9. ↑ Template:Cite Q
  10. ↑ Template:Cite Q
  11. ↑ Derivation of Human Embryonic Stem Cells by Immunosurgery
  12. ↑ Template:Cite Q
  13. ↑ Template:Cite Q
  14. ↑ Script error: No such module "citation/CS1".
  15. ↑ Template:Cite Q
  16. ↑ Script error: No such module "citation/CS1".
  17. ↑ Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".

External links

Template:Scholia

Template:Authority control

Retrieved from "http://debianws.lexgopc.com/wiki143/index.php?title=Douglas_A._Melton&oldid=4634844"